Kinetics of cytomegalovirus (CMV) pp65 and IE‐1‐specific IFNγ CD8+ and CD4+ T cells during episodes of viral DNAemia in allogeneic stem cell transplant recipients: Potential implications for the management of active CMV infection
- 25 May 2010
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 82 (7) , 1208-1215
- https://doi.org/10.1002/jmv.21799
Abstract
The dynamics of CMV pp65 and IE‐1‐specific IFNγ‐producing CD8+ (IFNγ CD8+) and CD4+ (IFNγ CD4+) T cells and CMV DNAemia were assessed in 19 pre‐emptively treated episodes of active CMV infection. Peripheral counts of IFNγ CD8+ and IFNγ CD4+ T cells inversely correlated with CMV DNAemia levels (P = P = 0.003, respectively). A threshold value of 1.3 cells/µl predicting CMV DNAemia clearance was established for IFNγ CD8+ T cells (PPV, 100%; NPV, 93%) and for IFNγ CD4+ T cells (PPV, 100%; NPV, 75%). Undetectable T‐cell responses were usually observed at the time of initiation of pre‐emptive therapy. Either a rapid (within 7 days) or a delayed (median 31 days) expansion of both T‐cell populations concomitant with CMV DNAemia clearance was observed in 5 and 8 episodes, respectively. An inconsistent or a lack of expansion of both T‐cell subsets was related to a persistent CMV DNAemia. Robust and maintained CMV‐specific T‐cell responses after CMV DNAemia clearance and cessation of antiviral therapy were associated with a null incidence of relapsing infections at least during the following month. Data obtained in the present study may be helpful in the design of therapeutic strategies for the management of active CMV infections in the allo‐SCT recipient. J. Med. Virol. 82: 1208–1215, 2010.Keywords
This publication has 24 references indexed in Scilit:
- Kinetics of interferon‐gamma producing cytomegalovirus (CMV)‐specific CD4+ and CD8+ T lymphocytes and the risk of subsequent CMV viremia after allogeneic hematopoietic stem cell transplantationTransplant Infectious Disease, 2009
- Quantification of DNA in Plasma by an Automated Real-Time PCR Assay (Cytomegalovirus PCR Kit) for Surveillance of Active Cytomegalovirus Infection and Guidance of Preemptive Therapy for Allogeneic Hematopoietic Stem Cell Transplant RecipientsJournal of Clinical Microbiology, 2008
- Monitoring cytomegalovirus IE‐1 and pp65‐specific CD4+ and CD8+ T‐cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivationsCytometry Part B: Clinical Cytometry, 2008
- Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infectionHaematologica, 2008
- CMV-specific T cell therapyBlood Cells, Molecules, and Diseases, 2008
- Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCTBone Marrow Transplantation, 2007
- Impact on the cytomegalovirus (CMV) viral load by CMV-specific T-cell immunity in recipients of allogeneic stem cell transplantationBone Marrow Transplantation, 2006
- Would monitoring CMV immune responses allow improved control of CMV in stem cell transplant patientsJournal of Clinical Virology, 2006
- Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivationBlood, 2003
- Cytomegalovirus‐Specific Cellular Immune Responses and Viremia in Recipients of Allogeneic Stem Cell TransplantsThe Journal of Infectious Diseases, 2001